ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 528 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $1,809,000 | -12.8% | 40,502 | -2.6% | 0.02% | 0.0% |
Q4 2019 | $2,074,000 | -5.4% | 41,591 | -15.4% | 0.02% | -11.1% |
Q3 2019 | $2,192,000 | -92.0% | 49,183 | -92.6% | 0.03% | -60.9% |
Q2 2019 | $27,531,000 | -3.7% | 666,935 | -5.7% | 0.07% | -6.8% |
Q1 2019 | $28,585,000 | -0.1% | 707,020 | -6.2% | 0.07% | -10.8% |
Q4 2018 | $28,618,000 | -9.8% | 753,497 | -6.0% | 0.08% | +3.8% |
Q3 2018 | $31,730,000 | +12.2% | 801,874 | -0.4% | 0.08% | +6.7% |
Q2 2018 | $28,275,000 | -1.5% | 805,314 | -1.9% | 0.08% | -2.6% |
Q1 2018 | $28,711,000 | +37.2% | 821,007 | +36.2% | 0.08% | +35.1% |
Q4 2017 | $20,922,000 | +20.4% | 602,932 | +17.5% | 0.06% | +11.8% |
Q3 2017 | $17,382,000 | -0.1% | 513,055 | +0.5% | 0.05% | -3.8% |
Q2 2017 | $17,395,000 | +11.6% | 510,275 | +1.9% | 0.05% | +8.2% |
Q1 2017 | $15,587,000 | +11.9% | 500,535 | -1.8% | 0.05% | +4.3% |
Q4 2016 | $13,930,000 | -27.7% | 509,873 | -13.1% | 0.05% | -27.7% |
Q3 2016 | $19,273,000 | +7.9% | 586,524 | -0.9% | 0.06% | +1.6% |
Q2 2016 | $17,866,000 | +3.6% | 591,769 | -3.4% | 0.06% | +3.2% |
Q1 2016 | $17,244,000 | -17.0% | 612,364 | +0.0% | 0.06% | -16.2% |
Q4 2015 | $20,787,000 | +9.1% | 612,272 | +2.3% | 0.07% | +4.2% |
Q3 2015 | $19,053,000 | +8.5% | 598,773 | +117.2% | 0.07% | +16.4% |
Q2 2015 | $17,560,000 | +17.7% | 275,618 | +26.4% | 0.06% | +17.3% |
Q1 2015 | $14,922,000 | +29.4% | 218,055 | +33.0% | 0.05% | +26.8% |
Q4 2014 | $11,536,000 | +49.0% | 163,905 | +51.3% | 0.04% | +46.4% |
Q3 2014 | $7,740,000 | -3.9% | 108,340 | 0.0% | 0.03% | -6.7% |
Q2 2014 | $8,051,000 | -45.8% | 108,340 | -52.7% | 0.03% | -48.3% |
Q1 2014 | $14,846,000 | -5.0% | 228,820 | -13.1% | 0.06% | -6.5% |
Q4 2013 | $15,627,000 | +28.6% | 263,220 | +12.5% | 0.06% | +19.2% |
Q3 2013 | $12,154,000 | +16.0% | 234,050 | +5.7% | 0.05% | +6.1% |
Q2 2013 | $10,475,000 | – | 221,454 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |